Pharmaceutical Excipients Market Size - By Product (Organic, Inorganic), Functionality (Binder, Suspension & Viscosity Agents, Filler & Diluent, Preservatives) Formulation (Oral {Tablet, Capsule}, Liquid, Parenteral, Topical) & Forecast, 2024

Description

Pharmaceutical excipients market size is estimated to register over 8% CAGR between 2024 and 2032. With the rising demand for dietary supplements alongside the increasing need for pharmaceuticals, excipients have grown essential as they help in enhancing drug formulations. These excipients improve stability, solubility, and bioavailability of active pharmaceutical ingredients, ultimately boosting the efficacy of drug formulations. The emergence of new drug delivery technologies is also presenting an opportunity for ingredient manufacturers to cater to evolving production needs.

Increased activities in contract development and manufacturing organizations will spur the market expansion. Outsourcing allows companies to focus on R&D while utilizing the expertise and infrastructure of CDMOs/CMOs for drug production. Legal standards for drug manufacturing require high-quality supplements from reliable suppliers, further boosting the product demand. For instance, in October 2023, Clariant launched three new VitiPure(R) excipients to enhance API formulations, especially for delicate products like mRNA vaccines and biologics.

The pharmaceutical excipients industry is segmented into product, functionality, formulation and region.

Based on product, the market value from the inorganic chemicals segment is projected to witness 7.9% growth rate through 2032. Inorganic chemicals are essential for pharmaceutical formulations to maintain quality and potency. They offer high levels of purity, stability, and compatibility with active ingredients. Surfactants provide unique functional properties like controlled release and binding. Inorganic additives, such as salts, minerals, and metals can also be used to customize formulations to meet specific requirements.

Pharmaceutical excipients market from the parenteral segment is anticipated to observe 7.9% CAGR from 2024 to 2032, owing to unique requirements for formulation and delivery of injectable pharmaceuticals. Parenteral products like injections and IV medications need additives for stability and compatibility with the active ingredient. Excipients are crucial in improving solubility, controlling delivery, and meeting regulatory standards for cleanliness and purity. As the demand for parenteral drug delivery continues to rise due to the increasing prevalence of chronic diseases and strong need for targeted therapies, the demand for quality developers for key infrastructure is increasing, favoring the segment growth.

Asia Pacific pharmaceutical excipients industry will record impressive growth, depicting an 8.4% CAGR through 2032. The expansion of the pharmaceutical industry in developing countries like China, India, and Southeast Asian countries is driving the demand for excipients due to increased healthcare infrastructure and spending, as well as the rising need for affordable medicines. Investments in healthcare infrastructure and increasing chronic diseases are also contributing to the need for excipients in APAC.

Product Code: 8780

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing demand for pharmaceutical and generic drugs
  - 3.2.1.2 Advancement in development of excipients
  - 3.2.1.3 Increased demand for excipients due to expiration of patents
  - 3.2.1.4 Increasing partnership and collaboration of pharmaceutical companies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Adverse effects of excipients
  - 3.2.2.2 Lack of proper approval process
3.3 Growth potential analysis
3.4 Pricing analysis
3.5 Technology analysis
3.6 Regulatory landscape
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Organic chemicals
- 5.2.1 Oleochemicals
  - 5.2.1.1 Fatty alcohols
  - 5.2.1.2 Mineral stearates
  - 5.2.1.3 Glycerin
  - 5.2.1.4 Other oleochemicals
- 5.2.2 Carbohydrates
  - 5.2.2.1 Sugar
    - 5.2.2.1.1 Actual sugar
    - 5.2.2.1.2 Sugar alcohols
    - 5.2.2.1.3 Artificial sweeteners
  - 5.2.2.2 Cellulose
    - 5.2.2.2.1 Microcrystalline cellulose
    - 5.2.2.2.2 Cellulose ethers
    - 5.2.2.2.3 CMC & croscarmellose sodium
    - 5.2.2.2.4 Cellulose esters
  - 5.2.2.3 Starch
    - 5.2.2.3.1 Modified starch
    - 5.2.2.3.2 Dried starch
    - 5.2.2.3.3 Converted starch
- 5.2.3 Petrochemicals
  - 5.2.3.1 Glycols
  - 5.2.3.2 Minerals hydrocarbons
  - 5.2.3.3 Acrylic polymers
  - 5.2.3.4 Other petrochemicals
- 5.2.4 Proteins
- 5.2.5 Other organic chemicals
5.3 Inorganic chemicals
- 5.3.1 Calcium phosphate
- 5.3.2 Metal oxides
- 5.3.3 Halites
- 5.3.4 Calcium carbonate
- 5.3.5 Calcium sulfate
- 5.3.6 Other inorganic chemicals
5.4 Other products

Chapter 6 Market Estimates and Forecast, By Functionality, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Binder
6.3 Suspension and viscosity agents
6.4 Glidants
6.5 Preservatives
6.6 Filler & diluent
6.7 Lubricant
6.8 Emulsifier
6.9 Disintegrant
6.10 Other functionalities

Chapter 7 Market Estimates and Forecast, By Formulation, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Oral
- 7.2.1 Tablet
- 7.2.2 Capsule
  - 7.2.2.1 Hard gelatin
  - 7.2.2.2 Soft gelatin
- 7.2.3 Other oral formulations
7.3 Liquid
7.4 Parenteral
7.5 Topical
7.6 Other formulations

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of Middle East and Africa

Chapter 9 Company Profiles

9.1 Air Liquide S.A.
9.2 Archer Daniels Midland Company
9.3 Ashland
9.4 Associated British Foods PLC
9.5 BASF SE
9.6 Croda International PLC
9.7 Evonik Industries AG
9.8 Innophos
9.9 Kerry Group plc
9.10 Merck KGaA

Pharmaceutical Excipients Market Size - By Product (Organic, Inorganic), Functionality (Binder, Suspension & Viscosity Agents, Filler & Diluent, Preservatives) Formulation (Oral {Tablet, Capsule}, Liquid, Parenteral, Topical) & Forecast, 2024 - 2032